Form 4: Aspira Women's Health President Acquires Stock Options

Sandra Milligan, President of Aspira Women's Health Inc., reports the acquisition of employee stock options.

Summary

• Sandra Milligan, President of Aspira Women's Health Inc., filed a Form 4 on May 6, 2024, reporting a transaction.
• On May 3, 2024, Milligan acquired 30,000 employee stock options with an exercise price of $3.21.
• The options vest in four equal annual installments starting April 1, 2025, and expire on May 3, 2034.
• Following the transaction, Milligan directly owns 30,000 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard executive compensation disclosure. The acquisition of stock options can be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of stock options by a company president can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies.

Stakeholder Impact

• The granting of stock options aligns the executive's interests with those of the shareholders, potentially incentivizing them to increase shareholder value.

Key Dates

Keywords

stock options, Form 4, Aspira Women's Health, insider trading, Sandra Milligan, AWH